OPKO Health, Inc. OPK has entered into a definitive agreement to
acquire Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e
Cosmeticos Ltda. Domiciled in Sao Paulo, Brazil, Silcon expands OPKO's
presence in Latin America and complements business activities of units in
Chile and Mexico.
Silcon broadens OPKO's reach in Latin America with this entry into the largest
market in the region. Beyond providing important cross marketing opportunities
for its growing portfolio of products, Silcon represents an important
strategic element for OPKO's diagnostic business; it permits commercialization
of the 4KScore™ prostate cancer test in Brazil as a reference laboratory test
while OPKO obtains local approval to market its point of care microfluidics
disposable test cassettes.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in